glp-1 news today food industry How WEIGHT-LOSS drugs are CHANGING the restaurant Lighter Carts and Shrinking Profits:

[5] [6] The American College of Cardiology, American Heart Association, and American Diabetes Association now recommend GLP-1 receptor agonists with proven cardiovascular benefit for patients with type 2 diabetes and established atherosclerotic cardiovascular disease, regardless of baseline hemoglobin A1c levels

However, current research on the BBB and methods for repairing it are predominantly limited to animal models

GHRH Pathway vs

Meanwhile, scientists have been uncovering new roles of GLP-1-based drugs beyond diabetes and obesity, with early data suggesting that they may be used to treat cardiovascular diseases, addictive disorders, and neurodegenerative disorders